{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:34:11Z","timestamp":1777581251908,"version":"3.51.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.nbd.2020.104994","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T14:09:18Z","timestamp":1593180558000},"page":"104994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis"],"prefix":"10.1016","volume":"143","author":[{"given":"Carmen","family":"Navarrete","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adela","family":"Garc\u00eda-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Garrido-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyre","family":"Mestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Feli\u00fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Guaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Calzado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-5842","authenticated-orcid":false,"given":"Eduardo","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104994_bb0005","series-title":"Comprehensive Natural Products II Chemistry and Biology Natural Products Drug Discovery","first-page":"205","volume":"3","author":"Appendino","year":"2010"},{"key":"10.1016\/j.nbd.2020.104994_bb0010","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.104994_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(87)90055-4","article-title":"Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases","volume":"78","author":"Bakker","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2020.104994_bb0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5152\/eurjrheum.2017.17025","article-title":"The endocannabinoid system in pain and inflammation: its relevance to rheumatic disease","volume":"4","author":"Barrie","year":"2017","journal-title":"Eur J Rheumatol."},{"key":"10.1016\/j.nbd.2020.104994_bb0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2010.08.011","article-title":"Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE","volume":"229","author":"Bennett","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104994_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/glia.22742","article-title":"Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo","volume":"63","author":"Bernal-Chico","year":"2015","journal-title":"Glia."},{"key":"10.1016\/j.nbd.2020.104994_bb0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/138161206780574579","article-title":"PPAR-gamma agonists as regulators of microglial activation and brain inflammation","volume":"12","author":"Bernardo","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2020.104994_bb0040","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/NEN.0b013e3181aba2c1","article-title":"Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells","volume":"68","author":"Bernardo","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104994_bb0045","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics."},{"key":"10.1016\/j.nbd.2020.104994_bb0050","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1523\/JNEUROSCI.4076-07.2008","article-title":"Callosal contributions to simultaneous bimanual finger movements","volume":"28","author":"Bonzano","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104994_bb0055","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1073\/pnas.0709906104","article-title":"Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons","volume":"105","author":"Brodbeck","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104994_bb0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cne.21307","article-title":"Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis","volume":"502","author":"Brown","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2020.104994_bb0065","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V","article-title":"Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats","volume":"89","author":"Caliph","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.nbd.2020.104994_bb0070","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1182\/blood-2005-09-3541","article-title":"Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells","volume":"107","author":"Calvani","year":"2006","journal-title":"Blood."},{"key":"10.1016\/j.nbd.2020.104994_bb0075","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pneurobio.2017.10.007","article-title":"The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: clues for other neuroinflammatory diseases","volume":"160","author":"Chiurchiu","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2020.104994_bb0080","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.nbd.2020.104994_bb0085","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/NEN.0b013e3182309ab1","article-title":"Peroxisome proliferator-activated receptor gamma agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory ca(2+) waves","volume":"70","author":"De Nuccio","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104994_bb0090","doi-asserted-by":"crossref","first-page":"21703","DOI":"10.1038\/srep21703","article-title":"The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-gamma and CB2 pathways","volume":"6","author":"del Rio","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104994_bb0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2013.06.004","article-title":"Induction of vascular remodeling: a novel therapeutic approach in EAE","volume":"333","author":"Esen","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2020.104994_bb0100","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1523\/JNEUROSCI.2900-16.2017","article-title":"2-Arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination","volume":"37","author":"Feliu","year":"2017","journal-title":"J. Neurosci."},{"issue":"Pt 3","key":"10.1016\/j.nbd.2020.104994_bb0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/120.3.393","article-title":"Axonal damage in acute multiple sclerosis lesions","volume":"120","author":"Ferguson","year":"1997","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2020.104994_bb0110","doi-asserted-by":"crossref","first-page":"A750","DOI":"10.1016\/j.jval.2015.09.2902","article-title":"Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and Fingolimod for the treatment of relapsing-remitting multiple sclerosis","volume":"18","author":"Fox","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.nbd.2020.104994_bb0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bcp.2018.07.047","article-title":"EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis","volume":"157","author":"Garcia-Martin","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2020.104994_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bcp.2019.02.029","article-title":"Cannabinoid derivatives acting as dual PPARgamma\/CB2 agonists as therapeutic agents for systemic sclerosis","volume":"163","author":"Garcia-Martin","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2020.104994_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrn2757","article-title":"Astroglial networks: a step further in neuroglial and gliovascular interactions","volume":"11","author":"Giaume","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2020.104994_bb0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40478-014-0084-z","article-title":"Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"2","author":"Girolamo","year":"2014","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.nbd.2020.104994_bb0135","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1073\/pnas.1920935117","article-title":"Chronic mild hypoxia accelerates recovery from preexisting EAE by enhancing vascular integrity and apoptosis of infiltrated monocytes","volume":"117","author":"Halder","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104994_bb0140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fnins.2018.00733","article-title":"The endocannabinoid system and oligodendrocytes in health and disease","volume":"12","author":"Ilyasov","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2020.104994_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yexcr.2004.09.032","article-title":"Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling","volume":"304","author":"Inestrosa","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.nbd.2020.104994_bb0150","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/dbio.2001.0208","article-title":"IGF-I synergizes with FGF-2 to stimulate oligodendrocyte progenitor entry into the cell cycle","volume":"232","author":"Jiang","year":"2001","journal-title":"Dev. Biol."},{"key":"10.1016\/j.nbd.2020.104994_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050500","article-title":"PPARgamma agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes","volume":"7","author":"Kanakasabai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104994_bb0160","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1023\/A:1025718513246","article-title":"Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs","volume":"20","author":"Khoo","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.nbd.2020.104994_bb0165","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2020.104994_bb0170","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","article-title":"The cuprizone animal model: new insights into an old story","volume":"118","author":"Kipp","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2020.104994_bb0175","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.0b013e3182872855","article-title":"Disability in multiple sclerosis: a reference for patients and clinicians","volume":"80","author":"Kister","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2020.104994_bb0180","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/glia.20043","article-title":"Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes","volume":"47","author":"Kleopa","year":"2004","journal-title":"Glia."},{"key":"10.1016\/j.nbd.2020.104994_bb0185","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0306-9877(95)90228-7","article-title":"Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus","volume":"45","author":"Klipper-Aurbach","year":"1995","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.nbd.2020.104994_bb0190","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0006-8993(87)90499-9","article-title":"Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice","volume":"425","author":"Kondo","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.104994_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2013.11.002","article-title":"Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS","volume":"287","author":"Kong","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.nbd.2020.104994_bb0200","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0361-9230(03)00095-9","article-title":"Neuropathology of multiple sclerosis-new concepts","volume":"61","author":"Kornek","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2020.104994_bb0205","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2020.104994_bb0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.expneurol.2009.10.009","article-title":"Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models","volume":"225","author":"Lassmann","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104994_bb0215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2020.104994_bb0220","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics."},{"key":"10.1016\/j.nbd.2020.104994_bb0225","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jnr.490310125","article-title":"CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes","volume":"31","author":"Louis","year":"1992","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2020.104994_bb0230","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.nbd.2020.104994_bb0235","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.M414390200","article-title":"Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation","volume":"280","author":"Luna-Medina","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104994_bb0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2011.11.099","article-title":"Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging","volume":"60","author":"MacKenzie-Graham","year":"2012","journal-title":"Neuroimage."},{"key":"10.1016\/j.nbd.2020.104994_bb0245","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00221-006-0517-4","article-title":"Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy","volume":"174","author":"Manson","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.nbd.2020.104994_bb0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00221-008-1276-1","article-title":"Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition","volume":"187","author":"Manson","year":"2008","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.nbd.2020.104994_bb0255","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/glia.22334","article-title":"Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis","volume":"60","author":"Markoullis","year":"2012","journal-title":"Glia."},{"key":"10.1016\/j.nbd.2020.104994_bb0260","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00401-012-0978-4","article-title":"Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter","volume":"123","author":"Markoullis","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2020.104994_bb0265","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: a complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.nbd.2020.104994_bb0270","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-5728(02)00205-9","article-title":"Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier","volume":"130","author":"McMahon","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104994_bb0275","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-018-1103-y","article-title":"Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy","volume":"15","author":"Navarrete","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2020.104994_bb0280","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12031-007-9027-5","article-title":"Gap junctions couple astrocytes and oligodendrocytes","volume":"35","author":"Orthmann-Murphy","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2020.104994_bb0285","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease--successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2020.104994_bb0290","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system?","volume":"50","author":"Pacher","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.nbd.2020.104994_bb0295","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/glia.23513","article-title":"Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination","volume":"66","author":"Papaneophytou","year":"2018","journal-title":"Glia."},{"key":"10.1016\/j.nbd.2020.104994_bb0300","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1016\/j.febslet.2011.04.037","article-title":"Mediators of oligodendrocyte differentiation during remyelination","volume":"585","author":"Patel","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2020.104994_bb0305","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104994_bb0310","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/bs.apha.2017.03.008","article-title":"The role of nuclear hormone receptors in cannabinoid function","volume":"80","author":"Pistis","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.nbd.2020.104994_bb0315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-pathol-011811-132443","article-title":"Pathology of demyelinating diseases","volume":"7","author":"Popescu","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.nbd.2020.104994_bb0320","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ng.943","article-title":"Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4","volume":"43","author":"Psychiatric, G. C. B. D. W. G","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2020.104994_bb0325","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/brain\/awm219","article-title":"Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis","volume":"130","author":"Rasmussen","year":"2007","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2020.104994_bb0330","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1073\/pnas.95.13.7614","article-title":"Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein","volume":"95","author":"Ricote","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104994_bb0335","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2020.104994_bb0340","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jnr.10596","article-title":"PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes","volume":"72","author":"Roth","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2020.104994_bb0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2011.02.010","article-title":"Neuroprotective agents: cannabinoids","volume":"142","author":"Sanchez","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.nbd.2020.104994_bb0350","doi-asserted-by":"crossref","first-page":"E2707","DOI":"10.1073\/pnas.1214019109","article-title":"Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells","volume":"109","author":"Schito","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104994_bb0355","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(05)60463-1","article-title":"Axon loss in multiple sclerosis","volume":"352","author":"Scolding","year":"1998","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2020.104994_bb0360","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fnagi.2017.00139","article-title":"Pharmacological modulation of functional phenotypes of microglia in neurodegenerative diseases","volume":"9","author":"Song","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2020.104994_bb0365","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pneurobio.2013.11.005","article-title":"Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance","volume":"114","author":"Stetler","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2020.104994_bb0370","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/01.jnen.0000248547.13176.9d","article-title":"Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatibility complex (MHC) haplotype-related","volume":"65","author":"Storch","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104994_bb0375","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2004.12.015","article-title":"Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis","volume":"161","author":"Storer","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104994_bb0380","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.it.2007.09.003","article-title":"Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms","volume":"28","author":"Straus","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2020.104994_bb0385","doi-asserted-by":"crossref","first-page":"11586","DOI":"10.1523\/JNEUROSCI.2045-11.2012","article-title":"Teneurin-4 is a novel regulator of oligodendrocyte differentiation and myelination of small-diameter axons in the CNS","volume":"32","author":"Suzuki","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104994_bb0390","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/cns.12506","article-title":"The cannabinoid CB1\/CB2 agonist WIN55212.2 promotes oligodendrocyte differentiation in vitro and neuroprotection during the Cuprizone-induced central nervous system demyelination","volume":"22","author":"Tomas-Roig","year":"2016","journal-title":"CNS Neurosci Ther."},{"key":"10.1016\/j.nbd.2020.104994_bb0395","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2020.104994_bb0400","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1002\/jnr.22058","article-title":"Distinct modes of migration position oligodendrocyte precursors for localized cell division in the developing spinal cord","volume":"87","author":"Tsai","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2020.104994_bb0405","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1093\/emboj\/17.13.3619","article-title":"Identification of novel stress-induced genes downstream of chop","volume":"17","author":"Wang","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2020.104994_bb0410","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ana.1077","article-title":"Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage","volume":"50","author":"Werner","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104994_bb0415","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1471-4159.2007.04875.x","article-title":"Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis","volume":"103","author":"Xu","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104994_bb0420","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS."},{"key":"10.1016\/j.nbd.2020.104994_bb0425","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.2174\/092986711797200426","article-title":"Hypoxia inducible factor-1 as a target for neurodegenerative diseases","volume":"18","author":"Zhang","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.nbd.2020.104994_bb0430","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.brainres.2005.12.061","article-title":"Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity","volume":"1073\u20131074","author":"Zhao","year":"2006","journal-title":"Brain Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120302692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120302692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:20:55Z","timestamp":1760851255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120302692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":86,"alternative-id":["S0969996120302692"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104994","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21717\/v1","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104994"}}